Does Spruce Biosciences (SPRB) Have the Potential to Rally 208.32% as Wall Street Analysts Expect?

Shares of Spruce Biosciences, Inc. (SPRB) have gained 10.4% over the past four weeks to close the last trading session at $64.3, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $198.25 indicates a potential upside of 208.3%.The mean estimate comprises four short-term price targets with a standard deviation of $61.58. While the lowest estimate of $140.00 indicates an 117.7% incre ...